While Abbott Labs doesn't report its next bout of earnings until October, positive investor sentiment should continue to fuel this solid company's rise in the market.

In addition to an underleveraged balance sheet and more than $1 billion in cash, this recession-resistant defense contractor has an order backlog that should last them the next 2.5 years.

As unemployment rises, so does enrollment for colleges. And this for-profit college is one of the best-positioned to profit as a result.

The world's largest steel producer is poised to profit from growth in development in emerging markets.

With some of the highest-performing supermarket brands under the SUPERVALU umbrella, this stock should only do better as the recession unwinds.